View All ZS OfficesZS Oncology Value Watchdog Report
ASCO 2016: Spotlight on Value
At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives. We identified five key initiatives that are likely to influence the oncology practice going forward. The results of our ASCO physician survey reveal how MDs currently regard and use value frameworks, as well as their perceptions and potential adoption of biosimilars. This report summarizes value initiatives, MD opinions on value, and provides recommendations for manufacturers.
By clicking on the button above, I agree to the Terms and Conditions of the site and the ZS Privacy Policy, which outlines our data management processes.
